Feedback PLC (LON:FDBK) was a top gainer in early trading Wednesday as it secured a software licence and distribution agreement for its TexRAD technology with General Electric Healthcare (GEHC), a subsidiary of US conglomerate General Electric (NYSE:GE).
The AIM-listed medical imaging company said the agreement granted GEHC non-exclusive global rights to offer Feedback’s TexRAD texture analysis software for medical imaging research applications.
The group added that India would be the first market in which TexRAD would be offered under the new agreement through Wipro – GE Healthcare India.
Feedback said the development of sales and customer engagement in India via GEHC would build on its existing customer base and that it would also be working with other GEHC affiliates to identify additional territories for its TexRAD offering.
David Crabb, Feedback chief executive, said in a statement: "We are delighted to be working with GE Healthcare as a major provider of medical imaging equipment and services in India, demonstrated by their commitment and investment in this market.
He added: “This global distribution agreement will further our international expansion, ensuring that our technology continues to be used by the world's leading institutions to expedite research in this important field."
Feedback shares were up 46.7% at 2.7p.